These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 34237459)
1. A commentary on the development of engineered phage as therapeutics. Barnard AML; Fairhead HIM Drug Discov Today; 2021 Sep; 26(9):2095-2098. PubMed ID: 34237459 [TBL] [Abstract][Full Text] [Related]
2. The Medicinal Phage-Regulatory Roadmap for Phage Therapy under EU Pharmaceutical Legislation. Faltus T Viruses; 2024 Mar; 16(3):. PubMed ID: 38543808 [TBL] [Abstract][Full Text] [Related]
3. [Creation of synthetic bacterial viruses]. Ando H Nihon Saikingaku Zasshi; 2018; 73(4):201-210. PubMed ID: 30487377 [TBL] [Abstract][Full Text] [Related]
4. Engineering therapeutic phages for enhanced antibacterial efficacy. Meile S; Du J; Dunne M; Kilcher S; Loessner MJ Curr Opin Virol; 2022 Feb; 52():182-191. PubMed ID: 34952266 [TBL] [Abstract][Full Text] [Related]
5. Approaches to optimize therapeutic bacteriophage and bacteriophage-derived products to combat bacterial infections. Reuter M; Kruger DH Virus Genes; 2020 Apr; 56(2):136-149. PubMed ID: 32036540 [TBL] [Abstract][Full Text] [Related]
6. Construction of a genetically modified T7Select phage system to express the antimicrobial peptide 1018. Lemon DJ; Kay MK; Titus JK; Ford AA; Chen W; Hamlin NJ; Hwang YY J Microbiol; 2019 Jun; 57(6):532-538. PubMed ID: 31054139 [TBL] [Abstract][Full Text] [Related]
8. Synthetic engineering and biological containment of bacteriophages. Mitsunaka S; Yamazaki K; Pramono AK; Ikeuchi M; Kitao T; Ohara N; Kubori T; Nagai H; Ando H Proc Natl Acad Sci U S A; 2022 Nov; 119(48):e2206739119. PubMed ID: 36409909 [TBL] [Abstract][Full Text] [Related]
9. Phage Therapy in the Twenty-First Century: Facing the Decline of the Antibiotic Era; Is It Finally Time for the Age of the Phage? Hesse S; Adhya S Annu Rev Microbiol; 2019 Sep; 73():155-174. PubMed ID: 31185183 [TBL] [Abstract][Full Text] [Related]
10. Ameliorating the antimicrobial resistance crisis: phage therapy. Saha D; Mukherjee R IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079 [TBL] [Abstract][Full Text] [Related]
11. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future. Łobocka M; Dąbrowska K; Górski A BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767 [TBL] [Abstract][Full Text] [Related]
13. Phage Therapy: The Pharmacology of Antibacterial Viruses. Danis-Wlodarczyk K; Dąbrowska K; Abedon ST Curr Issues Mol Biol; 2021; 40():81-164. PubMed ID: 32503951 [TBL] [Abstract][Full Text] [Related]
14. Making the leap from technique to treatment - genetic engineering is paving the way for more efficient phage therapy. Lewis JM; Williams J; Sagona AP Biochem Soc Trans; 2024 Jun; 52(3):1373-1384. PubMed ID: 38716972 [TBL] [Abstract][Full Text] [Related]
15. Phage Therapy Approaches to Reducing Pathogen Persistence and Transmission in Animal Production Environments: Opportunities and Challenges. Colavecchio A; Goodridge LD Microbiol Spectr; 2017 Jun; 5(3):. PubMed ID: 28664828 [TBL] [Abstract][Full Text] [Related]